Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gartner Inc (IT) vs 22nd Century Group Inc (XXII) Price & Performance

Gartner IncTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Gartner Inc vs 22nd Century Group Inc — how do they compare? Gartner Inc trades at $195.3 (market cap $12.34B), while 22nd Century Group Inc trades at $0.89 (market cap $621.67K). The key difference: Gartner Inc is far larger — about 19849.8× 22nd Century Group Inc's market cap, and Gartner Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gartner Inc for 64 Days and 22nd Century Group Inc for 32 Days on average.

ITXXII
Market Cap
$12.34B$621.67K
Volume
919,80945,625
Sector
TechnologyConsumer Staples
52-Week High
$258.17$483.00
52-Week Low
$125.68$0.80
Typical Hold Time
64 Days32 Days
Enterprise Value
$14.08B-$3.69M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gartner Inc

Gartner (IT) trades at $185.77, up 0.46% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company shows robust profitability with a 69.63% gross margin and 12% net income margin, though 2025 net income declined to $729 million. Recent news highlights AI advisory demand and a shareholder investigation, while analyst consensus is mixed with a $174.63 price target below the current price.

Outlook remains supported by high ROE and consulting industry growth, but risks include the shareholder fiduciary probe and volatile cash flows. The stock faces resistance near $188, with valuation metrics like P/E of 17.57 appearing reasonable if earnings stabilize.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IT

No sentiment data available yet.

XXII
3% Buy97% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Gartner Inc

Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.

Read more on IT →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →